Investing.com - Abbott Labs announced fourth quarter earnings that matched analysts' expectations on Wednesday and revenue that topped forecasts.
The company reported earnings per share of $0.95 on revenue of $8.31B. Analysts polled by Investing.com anticipated EPS of $0.95 on revenue of $8.26B. That was in comparison to EPS of $0.81 on revenue of $7.77B in the same quarter a year earlier. Abbott Labs had announced EPS of $0.84 on revenue of $8.08B in the previous quarter.
Analysts are forecasting EPS of $0.73 and revenue of $8B in the next quarter.
Abbott Labs share's are up 3.3% from the beginning of the year , down-from-52-week-high.
Abbott Labs follows other major Healthcare sector earnings this month
On Wednesday, J&J reported fourth quarter EPS of $1.88 on revenue of $20.75B, compared to a forecasts for EPS of $1.87 on revenue of $20.78B.
Novocure Ltd earnings beat analysts' expectations on Thursday, October 31, 2019, with third quarter EPS of $0.02 on revenue of $92.06M. Investing.com analysts anticipated EPS of $-0.04 on revenue of $86.94M
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar